Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies.
Journal: The European respiratory journal
Published: January 18, 2020
Detection of alpha-1 antitrypsin deficiency: the past, present and future.
Journal: Orphanet journal of rare diseases
Published: January 16, 2020
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.
Journal: The Lancet. Respiratory medicine
Published: August 10, 2018
Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis.
Journal: Advances in therapy
Published: February 11, 2018
The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis.
Journal: The European respiratory journal
Published: September 25, 2017
Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: May 03, 2012
Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trial.
Journal: Respiratory medicine
Published: September 30, 2011
Showing 1-7 of 7
Last Updated: 09/26/2026